1. Teelmann, K., Hohbach, C. & Lehmann, H. Arch. Toxicol. 59, 195–200 (1986).
2. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (1997). Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S6_R1/Step4/S6_R1_Guideline.pdf
(ICH, 1997).
3. Bailey, J., Capaldo, T., Conlee, K., Thew, M. & Pippin, J. Nat. Med. 14, 1011–1012; discussion 1012–1013 (2008).
4. European Medicines Agency.
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000240/human_med_001023.jsp&mid=WC0b01ac058001d124
(EMA, 2008).
5. European Medicines Agency.
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000582/human_med_000663.jsp&mid=WC0b01ac058001d124#
(EMA, 2006).